Skip to main content
AseBio - Asociación Empresas Biotecnología
  • Partner area
  • Contact
  • English
    • Español
    • English
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
  • Instagram
Promoting biotechnology in Spain
  • Become a member
  • Asebio Report
AseBio - Asociación Empresas Biotecnología
  • ABOUT ASEBIO

    • About us
    • Mission and values
    • Ethical code
    • Collaborations
  • MEMBERS

    • Directory
    • What we offer
    • How to join
  • WORKING AREAS

    • Healthcare
    • Sustainability
    • ECOSYSTEM
    • Social impact
    • Internationalization
  • KNOW THE SECTOR

    • ¿Qué es la biotecnología?
    • Asebio Report
    • Documents
    • Pipelines
  • NEWS & EVENTS

    • News
    • Premios AseBio
    • Press
    • Events
    • Job opportunities
    • Media library
  • Partner area
  • Contact
  • English
    • Español
    • English
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
  • Instagram
AseBio - Asociación Empresas Biotecnología
  1. Home
  2. Healthcare
  3. Biosimilars

Biosimilars

Imagen del ADN

Biotechnology and DNA: The duo paving the way for the era of customization in health and a...

25/04/2024

Next-generation DNA sequencing has a significant impact on personalized medicine, genomic research, and the...

AseBio
Biotecnologia

Sustainable agriculture, new food sources, protection against infectious diseases or waste...

26/03/2024
Healthcare
Biosimilars
Rare diseases
Climate change
Agrifood
Food & feed
Agriculture

Biotechnology provides solutions through plant genetic engineering, the revaluation of food industry by-products, new...

AseBio
biotecnologia

Sustainable agriculture, new food sources, protection against infectious diseases or waste...

25/03/2024

Humanity is at a critical moment for its future, with the need to promote more sustainable economic models that respond...

AseBio
Biosimilars-Latam-Biotech

Biosimilars LatAm - Europe 2024

Viena
Austria
Del
19/06/2024
to
21/06/2024
Biosimilars
International
3p

3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the M...

11/07/2022
Healthcare
Biosimilars
Industrial biotechnology

Mucormycosis is a difficult to treat invasive fungal infection with high mortality

Partners
-
3PBIOVIAN
Subscribe to Biosimilars

ASEBIO · DIEGO DE LEÓN, Nº 49, 1º IZQDA, 28006 MADRID (ESPAÑA) TEL: +34 91 210 93 10 / +34 91 210 93 74

secretariageneral@asebio.com  Twitter  LinkedIn  Facebook  YouTube  Instagram

 

ASEBIO · DIEGO DE LEÓN, Nº 49, 1º IZQDA, 28006 MADRID (ESPAÑA)

TEL: +34 91 210 93 10 / +34 91 210 93 74

FAX: +34 91 250 00 63

secretariageneral@asebio.com

Image removed.  Image removed.  Image removed.  Image removed.  Instagram

 

  • Copyright ASEBIO 2018
  • Legal Notice
  • Privacy Policy
  • Cookies Policy